Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

M. Beresford, R. Primhak, N. Subhedar, N J Shaw

    Research output: Contribution to journalArticle

    14 Citations (Scopus)


    In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
    Original languageEnglish
    Pages (from-to)F62-F63
    JournalArchives of Disease in Childhood - Fetal and Neonatal Edition
    Issue number1
    Publication statusPublished - 2002


    Cite this